He mentioned the r+d rebate, that I estimate will come in at 4.5M in q1 next year. So as long as they have enough to get to readout, with all indications being that they will, I am ok with the financial side. The extra 4.5M will give them enough runway to consider their next moves in what will be a far cheaper 2025 if all current trials are completed.
I have held companies with hefty balance sheets and poor trial outcomes.... the extra money in the bank was useless. Get to readout, and take it from there imo
Share Cafe webinar 9th August, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $3.04K | 865.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 38 | 49239172 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127041874 | 18 |
View Market Depth
| Last trade - 15.42pm 12/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |